Compare Bombay Oxygen with Similar Stocks
Stock DNA
Non Banking Financial Company (NBFC)
INR 299 Cr (Micro Cap)
19.00
23
0.18%
0.00
3.08%
0.57
Total Returns (Price + Dividend) 
Latest dividend: 35 per share ex-dividend date: Jul-08-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Bombay Oxygen Investments Ltd is Rated Sell
Bombay Oxygen Investments Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Bombay Oxygen Investments Ltd is Rated Sell
Bombay Oxygen Investments Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date analysis of the company’s standing.
Read full news article Announcements 
Closure of Trading Window
26-Mar-2026 | Source : BSEIntimation of Closure of Trading Window from 1st April 2026 till 48 hours after the declaration of the Audited Financial Results of the Company for the quarter and year ending 31st March 2026 to the stock exchange
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Feb-2026 | Source : BSEIntimation of Newspaper Publication of Financial Results in accordance with Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Board Meeting Outcome for Outcome Of The Board Meeting
13-Feb-2026 | Source : BSEPlease find attached Outcome of the Board Meeting held today i.e 13th February 2026
Corporate Actions 
No Upcoming Board Meetings
Bombay Oxygen Investments Ltd has declared 35% dividend, ex-date: 08 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
M Ramnarain Pvt Ltd. (22.41%)
Shubh Pharma Pvt Ltd (3.75%)
14.64%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 282.63% vs -119.73% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 275.48% vs -121.54% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -56.24% vs 47.71% in Sep 2024
Growth in half year ended Sep 2025 is -58.03% vs 44.10% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.44% vs -40.82% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -5.50% vs -39.04% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -71.47% vs 2,603.82% in Mar 2024
YoY Growth in year ended Mar 2025 is -69.60% vs 1,070.73% in Mar 2024







